C-peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
2002

C-peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): Zhen-guo Li, Weixian Zhang, Anders A. F. Sima

Primary Institution: Wayne State University School of Medicine

Hypothesis

C-peptide replacement can prevent hippocampal apoptosis and neuronal loss in type 1 diabetic BB/W rats.

Conclusion

C-peptide replacement in type 1 diabetic BB/W rats protects against hippocampal apoptosis and neuronal loss.

Supporting Evidence

  • C-peptide replacement prevented DNA laddering in the hippocampus of diabetic rats.
  • Diabetic rats showed a significant loss of CA1 neurons after 8 months, which was reduced with C-peptide.
  • C-peptide administration normalized IGF expression levels in the hippocampus.
  • Apoptosis was demonstrated in diabetic rats but not in those treated with C-peptide.

Takeaway

This study found that giving C-peptide to diabetic rats helps protect their brain cells from dying.

Methodology

The study involved diabetic BB/W rats treated with C-peptide and assessed for neuronal apoptosis and IGF expression.

Limitations

The study was conducted on animal models, which may not fully represent human conditions.

Participant Demographics

Male BB/W rats, both diabetic and non-diabetic.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/15604280290013991

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication